Explore IND-Enabling Services For Highly Potent Molecules

Eurofins CDMO Alphora is a Canadian-based contract development and manufacturing organization (CDMO), approved by both the U.S. FDA and Health Canada. We specialize in process development and analytical chemistry, with expertise spanning both non-GMP and GMP scale-up activities. Our focus is on the development and manufacture of complex small-molecule APIs, including highly potent compounds that require advanced technical capabilities and stringent safety controls.

From early-phase IND-enabling studies through to late-stage development and full commercialization, we provide end-to-end support tailored to the needs of emerging biotech innovators as well as established pharmaceutical companies. With a proven track record in solving challenging chemistry problems and delivering high-quality API supply, Eurofins CDMO Alphora is a trusted partner in advancing innovative therapies from the lab bench to the market.